| Bioactivity | AZD8309 is an orally active antagonist of CXCR2. AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseases[1]. |
| In Vivo | AZD8309 (50 mg/kg; 口服给药; 每天 2 次) 降低小鼠实验性胰腺炎中性粒细胞迁移和胰腺蛋白酶激活[1]。 Animal Model: |
| Name | AZD8309 |
| CAS | 333742-48-6 |
| Formula | C15H14F2N4O2S2 |
| Molar Mass | 384.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Malla SR, et al. Effect of oral administration of AZD8309, a CXCR2 antagonist, on the severity of experimental pancreatitis. Pancreatology. 2016 Sep-Oct;16(5):761-9. |
AZD8309
CAS: 333742-48-6 F: C15H14F2N4O2S2 W: 384.42
AZD8309 is an orally active antagonist of CXCR2. AZD8309 has the ability to regulate the transmigration of neutrophils.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.